 AUSTIN, TX ACCESSWIRE April 13, 2020 Apollo Endosurgery, Inc. Apollo APEN, a global leader in less invasive medical devices for gastrointestinal and bariatric procedures announced today that the US Food and Drug Administration FDA has completed the review of the final Post-Approval Study PAS Report for the Orbera Intragastric Balloon System and accepted that all post-approval study requirements have been fulfilled. The ORBERA Post Approval Study was a requirement following the US FDAs approval of ORBERA in August of 2015. 